(0.56%) 5 075.00 points
(0.32%) 38 192 points
(0.77%) 17 573 points
(0.68%) $79.54
(2.33%) $1.977
(0.20%) $2 315.70
(-0.22%) $26.69
(0.98%) $964.30
(0.12%) $0.934
(0.31%) $11.06
(0.02%) $0.799
(0.44%) $93.68
-0.59% $ 32.09
Live Chart Being Loaded With Signals
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand...
Stats | |
---|---|
Объем за сегодня | 38 599.00 |
Средний объем | 42 879.00 |
Рыночная капитализация | 6.20B |
EPS | $0.269 ( 2020-09-29 ) |
Last Dividend | $0.570 ( 2023-09-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 24.13 |
ATR14 | $0.0290 (0.09%) |
Объем Корреляция
EBOS Group Ltd Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
EBOS Group Ltd Корреляция - Валюта/Сырье
EBOS Group Ltd Финансовые показатели
Annual | 2023 |
Выручка: | $13.32B |
Валовая прибыль: | $1.70B (12.76 %) |
EPS: | $1.450 |
FY | 2023 |
Выручка: | $13.32B |
Валовая прибыль: | $1.70B (12.76 %) |
EPS: | $1.450 |
FY | 2022 |
Выручка: | $11.90B |
Валовая прибыль: | $1.38B (11.60 %) |
EPS: | $1.270 |
FY | 2021 |
Выручка: | $9.89B |
Валовая прибыль: | $1.07B (10.78 %) |
EPS: | $1.232 |
Financial Reports:
No articles found.
EBOS Group Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.380 (N/A) |
$0 (N/A) |
$0.426 (N/A) |
$0 (N/A) |
$0.570 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.178 | 2014-03-07 |
Last Dividend | $0.570 | 2023-09-07 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $6.19 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.85 | -- |
Div. Sustainability Score | 8.16 | |
Div.Growth Potential Score | 2.85 | |
Div. Directional Score | 5.50 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
MCY.AX | Ex Dividend Knight | 2023-09-13 | Semi-Annually | 0 | 0.00% | |
TGF.AX | Ex Dividend Junior | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
CUV.AX | Ex Dividend Junior | 2023-09-05 | Annually | 0 | 0.00% | |
NHF.AX | Ex Dividend Knight | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
YAL.AX | Ex Dividend Knight | 2023-09-05 | Annually | 0 | 0.00% | |
FGG.AX | Ex Dividend Junior | 2023-10-05 | Annually | 0 | 0.00% | |
PMV.AX | Ex Dividend Knight | 2023-06-20 | Semi-Annually | 0 | 0.00% | |
ARG.AX | Ex Dividend Knight | 2023-08-25 | Semi-Annually | 0 | 0.00% | |
IFL.AX | Ex Dividend Junior | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
SDG.AX | Ex Dividend Knight | 2023-10-24 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0203 | 1.500 | 9.59 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0367 | 1.200 | 8.78 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0972 | 1.500 | -0.0316 | -0.0474 | [0.1 - 1] |
payoutRatioTTM | 0.823 | -1.000 | 1.770 | -1.770 | [0 - 1] |
currentRatioTTM | 1.131 | 0.800 | 9.34 | 7.48 | [1 - 3] |
quickRatioTTM | 0.643 | 0.800 | -0.923 | -0.738 | [0.8 - 2.5] |
cashRatioTTM | 0.0797 | 1.500 | -0.668 | -1.002 | [0.2 - 2] |
debtRatioTTM | 0.199 | -1.500 | 6.68 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 5.16 | 1.000 | 9.20 | 9.20 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.734 | 2.00 | 9.42 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.063 | 2.00 | 9.47 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.527 | -1.500 | 7.89 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0737 | 1.000 | -2.11 | -2.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0367 | 1.000 | -1.266 | -1.266 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.238 | 1.000 | 9.79 | 9.79 | [0.2 - 2] |
assetTurnoverTTM | 1.809 | 0.800 | 1.270 | 1.016 | [0.5 - 2] |
Total Score | 8.16 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 23.77 | 1.000 | 7.70 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0972 | 2.50 | -0.0203 | -0.0474 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.063 | 2.00 | 9.65 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.94 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.734 | 2.00 | 9.42 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.823 | 1.500 | 1.770 | -1.770 | [0 - 1] |
pegRatioTTM | -1.070 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0262 | 1.000 | -1.844 | 0 | [0.1 - 0.5] |
Total Score | 2.85 |
EBOS Group Ltd
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; and clinical trial logistics. Additionally, the company provides pet nutrition products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа